Glucotrack (GCTK) Return on Sales (2014 - 2020)

Glucotrack has disclosed Return on Sales across 7 years of filings, most recently posting 0.59% for Q3 2020.

• Quarterly Return on Sales rose 294.0% year-over-year to 0.59% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.59% (up 73.0% YoY) and the FY2019 annual result came in at 0.17%, up 167.0% from the prior year.
• Return on Sales rose to 0.59% in Q3 2020, from 62.99% in the prior quarter.
• Over five years, Return on Sales peaked at 0.95% in Q4 2019 and troughed at 62.99% in Q2 2020.
• A 5-year average of 3.85% and a median of 0.1% in 2016 frame the typical range for Return on Sales.
• Biggest YoY gain for Return on Sales was 294 bps in 2020; the steepest drop was 6291 bps in 2020.
• Tracing GCTK's Return on Sales over 5 years: stood at 0.1% in 2016, then surged by 490 bps to 0.4% in 2017, then slumped by 257 bps to 0.63% in 2018, then soared by 251 bps to 0.95% in 2019, then tumbled by 37 bps to 0.59% in 2020.
• Business Quant data shows GCTK's Return on Sales at 0.59% in Q3 2020, 62.99% in Q2 2020, and 3.48% in Q1 2020.